brenda-database
Veto GatesRequired pass for any deployment consideration
| Dimension | Result | Detail |
|---|---|---|
| Scientific Integrity | PASS | The legacy audit did not indicate that retrieval outputs were presented as unsupported findings. |
| Practice Boundaries | PASS | Practice boundaries held because the package remained focused on source handling, lookup, or structured evidence use. |
| Methodological Ground | PASS | The legacy audit preserved a method-grounded interpretation of the Programmatic access to the BRENDA enzyme database via the SOAP API workflow. |
| Code Usability | PASS | The legacy evaluation did not preserve a usability failure in the packaged retrieval path. |
Core Capability88 / 100 — 8 Categories
Medical TaskExecution Average: 86 / 100 — Assertions: 15/20 Passed
The main issue in this canonical run was: The script execution path completed successfully for the documented case.
This variant a case was mostly intact, but the archived review centered its concern on: The script execution path completed successfully for the documented case.
This edge case was mostly intact, but the archived review centered its concern on: The script execution path completed successfully for the documented case.
The main issue in this variant b run was: The script execution path completed successfully for the documented case.
The preserved weakness for End-to-end case for SOAP-based programmatic access to the BRENDA database was concentrated in one point: The script execution path completed successfully for the documented case.
Key Strengths
- Primary routing is Evidence Insight with execution mode B
- Static quality score is 88/100 and dynamic average is 73.6/100
- Assertions and command execution outcomes are recorded per input for human review
- Execution verification summary: Script verification 0/1; adjustment=0. brenda_queries.py: rc=1